CTBP2 anticorps (AA 1-445)
Aperçu rapide pour CTBP2 anticorps (AA 1-445) (ABIN560519)
Antigène
Voir toutes CTBP2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-445
-
Fonction
- Mouse polyclonal antibody raised against a full-length recombinant CTBP2.
-
Séquence
- MALVDKHKVK RQRLDRICEG IRPQIMNGPL HPRPLVALLD GRDCTVEMPI LKDLATVAFC DAQSTQEIHE KVLNEAVGAM MYHTITLTRE DLEKFKALRV IVRIGSGYDN VDIKAAGELG IAVCNIPSAA VEETADSTIC HILNLYRRNT WLYQALREGT RVQSVEQIRE VASGAARIRG ETLGLIGFGR TGQAVAVRAK AFGFSVIFYD PYLQDGIERS LGVQRVYTLQ DLLYQSDCVS LHCNLNEHNH HLINDFTIKQ MRQGAFLVNA ARGGLVDEKA LAQALKEGRI RGAALDVHES EPFSFAQGPL KDAPNLICTP HTAWYSEQAS LEMREAAATE IRRAITGRIP ESLRNCVNKE FFVTSAPWSV IDQQAIHPEL NGATYRYPPG IVGVAPGGLP AAMEGIIPGG IPVTHNLPTV AHPSQAPSPN QPTKHGDNRE HPNEQ
-
Réactivité croisée
- Humain
-
Attributs du produit
- Antibody Reactive Against Recombinant Protein.
-
Immunogène
- CTBP2 (AAH02486, 1 a.a. ~ 445 a.a) full-length recombinant protein with GST tag.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Expression patterns of candidate susceptibility genes HNF1? and CtBP2 in prostate cancer: association with tumor progression." dans: Urologic oncology, Vol. 32, Issue 4, pp. 426-32, (2014) (PubMed).
-
: "Expression patterns of candidate susceptibility genes HNF1? and CtBP2 in prostate cancer: association with tumor progression." dans: Urologic oncology, Vol. 32, Issue 4, pp. 426-32, (2014) (PubMed).
-
- CTBP2 (C-terminal Binding Protein 2 (CTBP2))
-
Autre désignation
- CTBP2
-
Sujet
-
Full Gene Name: C-terminal binding protein 2
Synonyms: -
ID gène
- 1488
Antigène
-